Cargando…
The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
To properly evaluate the biological effects of immunotherapy, it is critical to utilize a model of cancer in immune-competent mice. Currently, MBT-2 is the most common murine bladder cancer cell line used in orthotopic bladder cancer models, even though this cell type often has an inappropriate gene...
Autores principales: | Seo, Ho Kyung, Shin, Seung-Phil, Jung, Na-Rae, Kwon, Whi-An, Jeong, Kyung-Chae, Lee, Sang-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584157/ https://www.ncbi.nlm.nih.gov/pubmed/28881578 http://dx.doi.org/10.18632/oncotarget.10784 |
Ejemplares similares
-
Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
por: Seo, Ho Kyung, et al.
Publicado: (2014) -
Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
por: Kim, Soon-Ja, et al.
Publicado: (2014) -
Tumor Establishment Features of Orthotopic Murine Bladder Cancer Models
por: Lee, Jin Seok, et al.
Publicado: (2012) -
Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity
por: Kim, Soo-Yeon, et al.
Publicado: (2017) -
Erratum: Correction of Acknowledgement. Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
por: Kim, Soon-Ja, et al.
Publicado: (2014)